Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

This important study presents compelling observational data supporting a role for transcription and polysome accumulation in the separation of newly replicated bacterial chromosomes. The study is ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...

Targeting specific translation factors that are altered in expression or activity in human cancers, and the specialized mRNA translation elements used preferentially in tumours, offers great ...

Robert F. Kennedy Jr. repeatedly asked to see "data" or "science" showing vaccines are safe — but when an influential Republican senator did so, he dismissed it.

Shares in CureVac have plummeted after a German court ruled that a patent it holds on mRNA-based COVID-19 vaccines was invalid. The validity of the patent is at the heart of patent litigation ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Typically miRNAs interact with specific mRNAs through complementary base-pairing to influence the translation or stability of the target mRNA molecule. Acquired miR-142 deficit in leukemic stem ...

Jan. 30, 2025 — A research group has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This groundbreaking research opens doors ...